(Q59567839)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12602919%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

title

Comparison of topoisomerase-IIalpha gene status between primary breast cancer and corresponding distant metastatic sites (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12602919%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12602919%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

Fátima Cardoso

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12602919%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

author name string

V Durbecq

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12602919%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

G Rouas

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12602919%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

J Y Leroy

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12602919%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

M Piccart

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12602919%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

D Larsimont

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12602919%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

language of work or name

English

0 references

publication date

1 February 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12602919%20AND%20SRC:MED&resulttype=core&format=json

Breast Cancer Research and Treatment

31 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12602919%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

volume

77

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12602919%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12602919%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

page(s)

199-204

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12602919%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1023/a:1021874224490

31 October 2019

exact match

0 references

cites work

Amplification and deletion of topoisomerase IIalpha associate with ErbB-2 amplification and affect sensitivity to topoisomerase II inhibitor doxorubicin in breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1021874224490

Ectopic expression of inactive forms of yeast DNA topoisomerase II confers resistance to the anti-tumour drug, etoposide

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1021874224490

Differential expression of DNA topoisomerase II alpha and -beta in P-gp and MRP-negative VM26, mAMSA and mitoxantrone-resistant sublines of the human SCLC cell line GLC4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1021874224490

Selection of a subpopulation with fewer DNA topoisomerase II alpha gene copies in a doxorubicin-resistant cell line panel

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1021874224490

An immunohistochemical evaluation of c-erbB-2 expression in human breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1021874224490

HER-2/neu gene amplification characterized by fluorescence in situ hybridization: poor prognosis in node-negative breast carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1021874224490

7 January 2021

Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1021874224490

7 January 2021

Overexpression of human DNA topoisomerase II alpha by fusion to enhanced green fluorescent protein.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1021874224490

7 January 2021

Evaluation of HER2, p53, bcl-2, topoisomerase II-alpha, heat shock proteins 27 and 70 in primary breast cancer and metastatic ipsilateral axillary lymph nodes.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1021874224490

7 January 2021

Breast cancer heterogeneity: evaluation of clonality in primary and metastatic lesions

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1021874224490

7 January 2021

c-erbB-2 protein overexpression and p53 immunoreaction in primary and recurrent breast cancer tissues

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1021874224490

7 January 2021

Patterns of her-2/neu amplification and overexpression in primary and metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1021874224490

7 January 2021

Stability of HER-2/neu expression over time and at multiple metastatic sites

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1021874224490

7 January 2021

Comparison of HER-2 status between primary breast cancer and corresponding distant metastatic sites

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1021874224490

7 January 2021

erbB-2 and response to doxorubicin in patients with axillary lymph node-positive, hormone receptor-negative breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1021874224490

7 January 2021

HER2 and choice of adjuvant chemotherapy for invasive breast cancer: National Surgical Adjuvant Breast and Bowel Project Protocol B-15

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1021874224490

7 January 2021

HER-2 and topo-isomerase IIalpha as predictive markers in a population of node-positive breast cancer patients randomly treated with adjuvant CMF or epirubicin plus cyclophosphamide

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1021874224490

7 January 2021

erbB-2, p53, and efficacy of adjuvant therapy in lymph node-positive breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1021874224490

7 January 2021

bcl-2, p53, and response to tamoxifen in estrogen receptor-positive metastatic breast cancer: a Southwest Oncology Group study

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1021874224490

7 January 2021